Early-Phase Oncology Research Expertise

Catalyst Oncology is a specialty oncology CRO focused entirely on helping biotechs advance the next generation of cancer therapies. We invest our time, scientific expertise, operational strength, and capital into supporting early-phase development — where uncertainty is high, speed is critical, and the right decisions can shape the entire trajectory of a program. Oncology clinical research is uniquely complex and constantly evolving, requiring deep disease-area insight, rigorous safety oversight, and the ability to adapt quickly as new data emerges.

At Catalyst, our priority is guiding promising therapies to proof-of-concept with precision and urgency, because every day saved in development matters profoundly to patients living with cancer and to the families who are waiting for better options.